Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cancer Researcher Wins Cytation™ 3 in BioTek's Contest!

Published: Saturday, April 12, 2014
Last Updated: Friday, April 11, 2014
Bookmark and Share
Dr. Jeff Peterson wins Cytation™ 3 cell imaging multi-mode reader in "Think Possible" Application Contest.

BioTek congratulates Dr. Jeff Peterson of the Fox Chase Cancer Center in Pennsylvania for winning a new Cytation™ 3 Cell Imaging Multi-Mode Reader in BioTek's "Think Possible" Application Contest.

Entrants were judged on a short essay that they submitted, detailing the application that they think is possible for their specific research using the Cytation 3. As an Associate Professor, Dr. Peterson studies chemical biology and kinase signaling in cancer.

"Multiplexing of disparate assays using multiple detection modalities is the future," Dr. Peterson wrote as part of his essay. "Cytation 3 is the first instrument that I am aware of that bridges the gap between imaging-based phenotypic screening and targeted assays using biochemical readouts. When both approaches are feasible simultaneously, the debate between phenotypic and targeted screening approaches dissolves to reveal a new world of possibilities."

As Dr. Peterson noted in his essay, patent pending Cytation 3 provides both quantitative and phenotypic cellular analyses by combining automated digital fluorescence microscopy and conventional microplate detection in a single platform.

Multi-channel widefield fluorescence and brightfield imaging are supported using high-intensity LED light sources and onboard filter cubes, and automated functions allow increased throughput compared to manual microscopy systems.

Hybrid Technology™ multi-mode detection combines high sensitivity filter-based detection and flexible monochromator-based detection for unmatched assay versatility now and in the future. This modular, parallel data acquisition platform allows scientists to collect more meaningful data, increase sample throughput, and reduce experimental time.

Cytation 3 is the recipient of three awards since its launch: the MipTec New Product Innovation Award, the SelectScience "Scientists' Choice Award for Best Drug Discovery Product" Award, and Thermo Fisher Scientific "Extraordinary New Product Line Award". It is also a finalist in the 2014 Edison Awards® competition.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers
Awarded by Promega Corporation, this certification validates an instrument to the highest performance levels and standards for the Dual-Luciferase® Reporter Assay System.
Monday, November 06, 2006
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!